AMBI / 919 (Ambi 40 1000 1000 mg / 40 mg)
Pill imprint AMBI / 919 has been identified as Ambi 40 1000 1000 mg / 40 mg.
Guaifenesin/phenylephrine is used in the treatment of sinus symptoms; cough and nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Guaifenesin/phenylephrine 1000 mg / 40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- AMBI / 919
- Strength:
- 1000 mg / 40 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- MCR American Pharmaceuticals Inc
More about guaifenesin/phenylephrine
Consumer resources
- Guaifenesin/phenylephrine
- Guaifenesin/phenylephrine controlled-release tablets
- Guaifenesin/phenylephrine liquid
- Guaifenesin/phenylephrine suspension
- Guaifenesin/phenylephrine sustained-release capsules
- More (2) »
- Other brands: Entex LA, Deconex, Rescon-GG, Miraphen PE, More (24) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
